| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| May 02, 2025 | May 08, 2025 | Carruthers R Michael CFO | Sell | Edgewise Therapeutics, Inc. | EWTX | $16.45 | $21,621 | -1.60% |
| Sep 20, 2024 | Sep 25, 2024 | Carruthers R Michael CFO | Sell | Edgewise Therapeutics, Inc. | EWTX | $28.57 | $4M | -94.77% |
| May 02, 2024 | May 03, 2024 | Carruthers R Michael CFO | Sell | Edgewise Therapeutics, Inc. | EWTX | $18.91 | $40,789 | -5.77% |
| Jan 23, 2024 | Jan 25, 2024 | Carruthers R Michael CFO | Sell | Edgewise Therapeutics, Inc. | EWTX | $15.78 | $1M | -75.62% |
| May 02, 2023 | May 03, 2023 | Carruthers R Michael CFO | Sell | Edgewise Therapeutics, Inc. | EWTX | $8.9 | $11,897 | -7.65% |
| Dec 02, 2016 | Dec 05, 2016 | Carruthers R Michael Exec VP CFO | Buy | Nivalis Therapeutics, Inc. | NVLS | $2.09 | $50,256 | +50.00% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.